US EditionNew Test to Diagnose Coeliac Disease
- Melbourne researchers developed a new blood test for coeliac disease after the Nexvax2 vaccine trial failed to work.
- The vaccine trial aimed to treat coeliac disease, but its failure led researchers to focus on diagnosis through immune markers like interleukin 2.
- The test mixes a blood sample with gluten fragments to detect T cells, diagnosing coeliac disease accurately without requiring patients to eat gluten.
- A study of 181 samples showed the test has 90 per cent accuracy and differentiates coeliac disease from gluten intolerance, which it excludes.
- The blood test could reduce invasive gastroscopies and gluten challenges, making diagnosis easier and is expected to be available within two years.
Insights by Ground AI
Does this summary seem wrong?
10 Articles
10 Articles
All
Left
4
Center
Right
1
9NewsReposted by 
MSN
MSNMelbourne researchers develop 'game-changer' new test to diagnose coeliac disease
Melbourne researchers have developed a "game changer" new blood test to replace the painful process of detecting coeliac disease.It is estimated that more than 350,000 Australians live with coeliac disease, a condition that scientists say is underdiagnosed.The current diagnostic process requires patients to consume gluten for weeks to ensure accurate test results, often triggering adverse reactions. READ MORE: 'Terrible tragedy': Mayor confirms …
·Australia
Read Full Article
Celiac disease is more than just abdominal pain – gluten intolerance can have serious consequences. Those affected must consistently renounce gluten.
Coverage Details
Total News Sources10
Leaning Left4Leaning Right1Center0Last UpdatedBias Distribution80% Left
Bias Distribution
- 80% of the sources lean Left
80% Left
L 80%
R 20%
Factuality
To view factuality data please Upgrade to Premium
